Characteristics, Comorbidities, Complications, and Outcomes Among 802 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 in a Community Hospital in Florida.
Orlando, Florida
comorbidities
complications
coronavirus disease 2019
epidemiology
mortality
severe acute respiratory syndrome coronavirus 2
Journal
Critical care explorations
ISSN: 2639-8028
Titre abrégé: Crit Care Explor
Pays: United States
ID NLM: 101746347
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
entrez:
3
6
2021
pubmed:
4
6
2021
medline:
4
6
2021
Statut:
epublish
Résumé
Coronavirus disease 2019 continues to increase throughout the United States. Despite the rapid progression of the disease, there is limited information of the factors associated with mortality in Florida. This study aims to review the demographics, characteristics, comorbidities, complications, and outcomes of hospitalized patients, and their association with mortality. Cohort study. A community-based tertiary-care hospital of Orlando Health, Orlando Regional Medical Center. Data of hospitalized patients who tested positive for severe acute respiratory syndrome coronavirus 2 between March 1, 2020, and August 31, 2020, at the Orlando Regional Medical Center. None. Main data assessed included patient demographics, clinical characteristics, comorbidities, complications, outcomes, and inhospital mortality. The median age for hospitalized patients was 61 years; among them, 56% were males. Most were of African American ( We identified an increase of severity of coronavirus disease 2019 within older patients of African American and Hispanic descent with comorbidities such as diabetes, coronary artery disease, congestive heart failure, chronic kidney disease, cancer, liver disease, or cerebrovascular disease. Noninvasive positive-pressure ventilation and high-flow nasal cannula oxygen may have helped avert mechanical ventilation, and this may have improved patient outcomes over the course of the study period.
Identifiants
pubmed: 34079947
doi: 10.1097/CCE.0000000000000416
pmc: PMC8162958
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0416Informations de copyright
Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.
Déclaration de conflit d'intérêts
We all certify that our affiliations with, or financial involvement with any organization, or entity with a financial interest in, or financial conflict with the subject matter, or materials discussed in the article are completely disclosed.
Références
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
Am J Emerg Med. 2020 Jul;38(7):1534-1535
pubmed: 32354529
Clin Infect Dis. 2020 Mar 16;:
pubmed: 32173725
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
JAMA Netw Open. 2020 Aug 3;3(8):e2018039
pubmed: 32809033
CMAJ. 2020 Jun 29;192(26):E694-E701
pubmed: 32461326
Front Med (Lausanne). 2020 Jun 11;7:295
pubmed: 32596248